Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Meletios Therapeutics logo — Fulfil the urgent, large and unmet medical need for antivira...

Meletios Therapeutics

Fulfil the urgent, large and unmet medical need for antiviral molecules.

Founded 2020 France France 8 employees Private Equity Total: $5.20M Biotechnology, Health and Wellness

General Information

Company Name Meletios Therapeutics
Founded Year 2020
Location France France +1
Employees 8
Industries Biotechnology, Health and Wellness
Funding Stage Private Equity
Social

Get notified when Meletios Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Meletios Therapeutics

Meletios Therapeutics is a biotechnology startup founded in 2020 in France, aiming to address the urgent, large, and unmet medical need for antiviral molecules. With a recent €2.50M grant investment from the European Innovation Council in November 2022, the company is positioned to advance its innovative solutions in the field of antiviral therapeutics. Specializing in the Biotechnology and Health and Wellness industries, Meletios Therapeutics is well-poised to make a significant impact in combatting viral diseases and improving global health outcomes.

Taxonomy: antiviral drugs, emerging diseases, host mechanisms, drug development, pathologies

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Private Equity Round •••••• 1
Investor
02 Nov 2022
Grant •••••• 1
Investor
02 Nov 2022

FAQ About Meletios Therapeutics

Fulfil the urgent, large and unmet medical need for antiviral molecules.
Meletios Therapeutics was founded in 2020.
Meletios Therapeutics is headquartered in France.
Meletios Therapeutics operates in the following industries: Biotechnology, Health and Wellness.
Meletios Therapeutics has approximately 8 employees.
Meletios Therapeutics has completed 2 funding rounds, raising a total of $5.20M. The latest funding stage is Private Equity.

We're actively collecting intelligence on Meletios Therapeutics.

Track Meletios Therapeutics to get notified

Don't just browse. Track.

Signal Tracker monitors Meletios Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy